Switch View
© PR Newswire
22.09.2025
ISIN: US4718711033
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Sept. 22, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR) betwe...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
Securities Fraud Investigation Into Jasper Therapeutics, Inc. (JSPR) Announced – Investors Who Lost Money Urged to Contact the Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON JASPER THERAPEUTICS, INC. (JSPR), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURS...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US00653Q1022
Adapthealth Corp
AHCO
LISTED
NASDAQ
AdaptHealth Corp. to Participate in Upcoming Investor Conference
News Preview
AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the Jefferies Healthcare Services Conference, being held in Nashville, on Monday, Se...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
22.09.2025
ISIN: CA60255C8850
Mind Medicine (MindMed) Inc
MNMD
LISTED
NASDAQ
MindMed Announces New Employee Inducement Grants
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to three newly hired non-executive employees consisting of options to purchase an aggregate of 182,800 commo...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
22.09.2025
ISIN: US24661P8077
Delcath Systems, Inc.
DCTH
LISTED
NASDAQ
Delcath Systems Announces Investigator-Initiated CHOPIN Phase 2 Trial Presentation at ESMO 2025 Congress
News Preview
Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the acceptance of an oral presentation on results from the investigator-initiated CHOPIN randomized Phase 2 trial at the 2025 European Society for Medical Oncology (ESMO) Annual Congress. Princi...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR) and reminds investors of the November 18, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
F...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Bristol Myers Squibb entscheidet sich für Veeva Vault CRM
News Preview
Für CRM der nächsten Generation mit tiefgreifenden, branchenspezifischen KI-Agenten
PLEASANTON, Kalifornien, 22. September 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) gab heute bekannt, dass Bristol Myers Squibb (BMS) sich verpflichtet hat, Veeva Vault CRM.
„Technologie verändert grundlegend die Art und Weise, wie wir mit unseren Kunden und...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US0017441017
AMN Healthcare Services Inc
AMN
LISTED
NYSE
AMN Healthcare Announces Pricing of Senior Notes Offering
News Preview
DALLAS, Sept. 22, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), announced today that its wholly owned subsidiary, AMN Healthcare, Inc., priced its previously announced private offering of $400.0 million aggregate principal amount of senior unsecured notes due 2031. The 2031 Notes will bear an interest rate of 6.500% per annu...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Kirby McInerney LLP Reminds Nutex Health Inc. Investors of Class Action Filing and Encourages Investors to Contact the Firm
News Preview
Kirby McInerney LLP reminds investors who purchased Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ:NUTX) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
If you s...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US57777K1060
MaxCyte Inc
MXCT
LISTED
NASDAQ
MaxCyte Announces Operational Restructuring to Reduce Costs and Accelerate Path to Profitability
News Preview
ROCKVILLE, Md., Sept. 22, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced a restructuring of its operations to better align resources with it...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US34965KAA51
Fortrea Holdings, Inc.
FTRE
LISTED
NASDAQ
Fortrea Appoints William Sharbaugh to Board of Directors
News Preview
DURHAM, N.C., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced the appointment of William Sharbaugh to the Company’s Board of Directors. Mr. Sharbaugh brings extensive healthcare experience in finance, operations, manufacturing, and quality to the pos...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US2183521028
Corcept Therapeutics Inc
CORT
LISTED
NASDAQ
Corcept to Present New Late-Breaking Data From Pivotal ROSELLA Trial of Relacorilant in Platinum-Resistant Ovarian Cancer at ESMO 2025
News Preview
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, will present new data from its pivotal Phase 3 ROSELLA trial of relacorilant plus nab-p...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
22.09.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Replimune Group, Inc. (“Replimune” or the “Company”) (NASDAQ: REPL) and reminds investors of the September 22, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
F...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) and reminds investors of the September 22, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi &...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
22.09.2025
ISIN: CA00143Y1034
AI-ML Innovations Inc.
AIML
LISTED
CSE
AIML Announces Closing of Oversubscribed Private Placement
News Preview
VANCOUVER, BC / ACCESS Newswire / September 22, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that Company completed its previously announced non-brokered private placement offering on September 4, 2025 on an oversubscribed basis.On September 4, 2025, the Company...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US55287L1017
MBX Biosciences, Inc.
MBX
LISTED
NASDAQ
MBX Biosciences Announces Proposed Public Offering
News Preview
CARMEL, Ind., Sept. 22, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that it has filed a registration statement on Form S-1 with the U.S....
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: FR0004163111
Genfit SA
GNFT
LISTED
EURONEXT
GENFIT Reports First-Half 2025 Financial Results and Provides Corporate Update
News Preview
Lille (France), Cambridge (Massachusetts, United States), (Zurich, Switzerland); September 22, 2025 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced its first half 2025 financial results and provided a corporate up...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US04272N1028
Arrivent Biopharma Inc
AVBP
LISTED
NASDAQ
ArriVent Appoints Brent S. Rice as Chief Commercial Officer
News Preview
NEWTOWN SQUARE, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced the appointment of Brent S. Rice as Chief Commercial Officer (CCO). Mr. Rice joins ArriVent w...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US08205P1003
Benitec Biopharma, Inc.
BNTC
LISTED
NASDAQ
Benitec Biopharma Releases Full Year 2025 Financial Results and Provides Operational Update
News Preview
Interim Clinical Study Results for Cohort 1 of the BB-301 Phase 1b/2a Treatment Study Anticipated in Q4 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: CA29842P1053
Eupraxia Pharmaceuticals Inc.
EPRX
LISTED
TSX
Eupraxia Pharmaceuticals Announces Proposed Public Offering of Common Shares
News Preview
VICTORIA, British Columbia, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, is pleased...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US5288723027
Lexicon Pharmaceuticals Inc
LXRX
LISTED
NASDAQ
Lexicon Pharmaceuticals Announces Update on Submission of Additional Data to U.S. FDA Supporting the Benefit-Risk Profile of Zynquista® in Type 1 Diabetes
News Preview
Data obtained from ongoing third-party funded, investigator-sponsored trials have been submitted in effort to address the December 2024 complete response letter...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Shareholder Alert: The Ademi Firm investigates whether Semler Scientific Inc. is obtaining a Fair Price for its Public Shareholders
News Preview
MILWAUKEE, Sept. 22, 2025 /PRNewswire/ -- The Ademi Firm is investigating Semler Scientific (Nasdaq: SMLR) for possible breaches of fiduciary duty and other violations of law in its transaction with Strive.
Click here to learn how...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. (LNTH) Investors: November 10, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
News Preview
RADNOR, Pa., Sept. 22, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Lantheus Holdings, Inc. ("Lantheus") (NASDAQ: LNTH) on behalf of those who purchased or otherwise acquired Lantheus securities between February 26, 2025,...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US1266501006
CVS Health Corp
CVS
LISTED
NYSE
Omnicare Initiates Voluntary Chapter 11 Process
News Preview
Company Intends to Use Process to Implement a Standalone Restructuring or Sale Strategy
Remains Focused on Delivering Safe and Reliable Pharmacy Services to All Customers
WOONSOCKET, R.I., Sept. 22, 2025 /PRNewswire/ -- Omnicare, LLC, a subsidiary of CVS Health (NYSE: CVS), today announced it has initiated a voluntary court-supervised Chapter 11...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Law Offices of Frank R. Cruz Encourages Cytokinetics, Incorporated (CYTK) Investors To Inquire About Securities Fraud Class Action
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Cytokinetics, Incorporated (“Cytokinetics” or the “Company”) (NASDAQ: CYTK) common stock between December 27, 2023 and May 6, 2025, inclusive (the “Class Period”). Cytokinetics investors have until November 17, 2025 to file a...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cytokinetics, Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
NEW YORK, Sept. 22, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cytokinetics, Incorporated ("Cytokinetics" or "the Company") (NASDAQ: CYTK) and certain of its officers....
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US59267L1070
Metsera, Inc.
MTSR
LISTED
NASDAQ
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ODP and MTSR on Behalf of Shareholders
News Preview
NEW YORK, Sept. 22, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
REPL Deadline: REPL Investors with Losses in Excess of $100K Have Opportunity to Lead Replimune Group, Inc. Securities Lawsuit Filed by The Rosen Law Firm
News Preview
NEW YORK, Sept. 22, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, 2024 and July 21, 2025, both dates inclu...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH INVESTOR DEADLINE: Lantheus Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
SAN DIEGO, Sept. 22, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Lantheus Holdings, Inc. (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, all dates inclusive (the "Class Period"), have until November 10, 2025 to seek appointment as lead plaintiff of the Lantheus class...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
22.09.2025
ISIN: US63633D1046
National Health Investors Inc
NHI
LISTED
NYSE
NHI Prices Offering of Senior Notes
News Preview
MURFREESBORO, TN / ACCESS Newswire / September 22, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today that it priced an offering of $350 million aggregate principal amount of 5.350% Senior Notes due 2033 (the "Notes"). The Notes will be issued at 98.903% of par value with a coupon of 5.350%. Interest on the Notes is payable...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
22.09.2025
ISIN: CA68237C1059
Onco-Innovations Limited
ONCO
LISTED
CSE
Onco-Innovations Appoints Dr. Michael Lock to Scientific & Clinical Advisory Board
News Preview
VANCOUVER, BC / ACCESS Newswire / September 22, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN: A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") is pleased to announce the appointment of Dr. Michael Lock, Professor in the Department of Oncology and the Department of Medical Biophysics at the University of Wester...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US17166A1016
Cibus Inc
CBUS
LISTED
NASDAQ
Cibus CEO to Highlight Gene Editing’s Role in Building Resilient Agriculture at UN Climate Week 2025
News Preview
SAN DIEGO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company specializing in the development and licensing of gene-edited plant traits, today announced that Peter Beetham, Co-Founder, President, and Interim Chief Executive Officer, will participate in a featured panel during UN Climate Week 2...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Bristol Myers Squibb Commits to Veeva Vault CRM
News Preview
For next-generation CRM with deep, industry-specific AI agents
PLEASANTON, Calif., Sept. 22, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Bristol Myers Squibb (BMS) has committed to Veeva Vault CRM.
"Technology is fundamentally reshaping the way we engage with our customers and the patients they serve," said Greg Meyers,...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Bristol Myers Squibb Commits to Veeva Vault CRM
News Preview
For next-generation CRM with deep, industry-specific AI agents
PLEASANTON, Calif., Sept. 22, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Bristol Myers Squibb (BMS) has committed to Veeva Vault CRM.
"Technol...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US74051N1028
Premier Inc
PINC
LISTED
NASDAQ
Shareholder Alert: The Ademi Firm investigates whether Premier Inc. is obtaining a Fair Price for its Public Shareholders
News Preview
MILWAUKEE, Sept. 22, 2025 /PRNewswire/ -- The Ademi Firm is investigating Premier (Nasdaq: PINC) for possible breaches of fiduciary duty and other violations of law in its transaction with Patient Square Capital.
Click here to lear...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US59267L1070
Metsera, Inc.
MTSR
LISTED
NASDAQ
Shareholder Alert: The Ademi Firm investigates whether Metsera Inc. is obtaining a Fair Price for its Public Shareholders
News Preview
MILWAUKEE, Sept. 22, 2025 /PRNewswire/ -- The Ademi Firm is investigating Metsera (Nasdaq: MTSR) for possible breaches of fiduciary duty and other violations of law in its transaction with Pfizer.
Click here to learn how to join ou...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: BE0003766806
Ion Beam Applications SA
IBAB
LISTED
EURONEXT
IBA – Transparency Notification
News Preview
...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
SMLR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Semler Scientific, Inc. Is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Semler Scientific, Inc. (NASDAQ: SMLR) to Strive, Inc. for 21.05 Class A common shares of Strive per share of Semler is fair to Semler shareholders.
Halper Sadeh encourages Semler shareholders to click here to learn more about their legal rights and options or co...
Themefolio
Profiler
Peergroup
© EQS Newswire
22.09.2025
ISIN: DE000A2P4LJ5
PharmaSGP Holding SE
PSG
LISTED
XETRA
PharmaSGP beruft außerordentliche Hauptversammlung zur Beschlussfassung über Squeeze-out ein
News Preview
PharmaSGP beruft außerordentliche Hauptversammlung zur Beschlussfassung über Squeeze-out ein
Gräfelfing, 22. September 2025 – Wie bereits in der Ad-hoc Mitteilung der PharmaSGP Holding SE vom 24. Juli 2025 bekanntgemacht, hat die FUTRUE GmbH der PharmaSGP Holding SE am 24. Juli 2025 mitgeteilt, dass ihr mehr als 95 % der Aktien an der PharmaSGP H......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.09.2025
ISIN: DE000A2P4LJ5
PharmaSGP Holding SE
PSG
LISTED
XETRA
PharmaSGP convenes extraordinary general meeting to resolve on Squeeze-out
News Preview
PharmaSGP convenes extraordinary general meeting to resolve on Squeeze-out
Gräfelfing, September 22, 2025 – As already announced in the ad hoc announcement by PharmaSGP Holding SE on July 24, 2025, FUTRUE GmbH informed PharmaSGP Holding SE on July 24, 2025 that it owns more than 95% of the shares in PharmaSGP Holding SE within the meaning of Sect......
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC LEI: 5493003YBCY4W1IMJU04 NET ASSET VALUE The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 19 September 2025 was 351.72p (cum income). For and on behalf of the B...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US30052C1071
Evolus Inc
EOLS
LISTED
NASDAQ
Top Miami Plastic Surgeon Dr. Benjamin Eskenazi Named Lead Consultant for Evolus' Evolysse™ Filler Launch
News Preview
Headline Summary: Board-certified plastic surgeon brings extensive expertise in facial anatomy and injectable treatments to support nationwide rollout of breakthrough hyaluronic acid technology. Partnership underscores Evolus' commitment to patient safety and provider education for their new FDA-approved filler line.
MIAMI BEACH, Fla., Sept. 22,...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: KR7328130000
Lunit Inc.
328130
LISTED
KOE
Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine
News Preview
Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities
SEOUL, South Korea, Sept. 22, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, and Agilent Technologies Inc. (NYSE: A), a globa...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Savara Inc.(SVRA) Shareholders
News Preview
NEW YORK, Sept. 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Savara Inc. (NASDAQ: SVRA).
Shareholders who purchased shares of SVRA during the class period listed are encouraged to conta...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. Class Action: The Gross Law Firm Reminds Lantheus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 10, 2025 - LNTH
News Preview
NEW YORK, Sept. 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Lantheus Holdings, Inc. (NASDAQ: LNTH).
Shareholders who purchased shares of LNTH during the class period listed are encoura...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Shareholders of LifeMD, Inc. Should Contact The Gross Law Firm Before October 25, 2025 to Discuss Your Rights - LFMD
News Preview
NEW YORK, Sept. 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD).
Shareholders who purchased shares of LFMD during the class period listed are encouraged to cont...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US02155H2004
Altimmune Inc
ALT
LISTED
NASDAQ
The Gross Law Firm Reminds Altimmune, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 6, 2025 - ALT
News Preview
NEW YORK, Sept. 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Altimmune, Inc. (NASDAQ: ALT).
Shareholders who purchased shares of ALT during the class period listed are encouraged to con...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
Replimune Group, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before September 22, 2025 to Discuss Your Rights - REPL
News Preview
NEW YORK, Sept. 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Replimune Group, Inc. (NASDAQ: REPL).
Shareholders who purchased shares of REPL during the class period listed are encourage...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Investors who lost money on Nutex Health Inc. (NUTX) should contact The Gross Law Firm about pending Class Action - NUTX
News Preview
NEW YORK, Sept. 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX).
Shareholders who purchased shares of NUTX during the class period listed are encouraged to...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Lost Money on Cytokinetics, Incorporated(CYTK)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
News Preview
NEW YORK, Sept. 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cytokinetics, Incorporated (NASDAQ: CYTK).
Shareholders who purchased shares of CYTK during the class period listed are enco...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Class Action Filed Against Semler Scientific, Inc. (SMLR) - October 28, 2025 Deadline to Join - Contact The Gross Law Firm
News Preview
NEW YORK, Sept. 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Semler Scientific, Inc. (NASDAQ: SMLR).
Shareholders who purchased shares of SMLR during the class period listed are encoura...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US90466Y1038
Unicycive Therapeutics, Inc.
UNCY
LISTED
NASDAQ
Lost Money on Unicycive Therapeutics, Inc.(UNCY)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
News Preview
NEW YORK, Sept. 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Unicycive Therapeutics, Inc. (NASDAQ: UNCY).
Shareholders who purchased shares of UNCY during the class period listed are en...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US64125C1099
Neurocrine Biosciences Inc
NBIX
LISTED
NASDAQ
Neurocrine Biosciences Presents Positive New Data from Phase 2 Study of Osavampator in Adults with Major Depressive Disorder
News Preview
SAN DIEGO, Sept. 22, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the presentation of new data from the Phase 2 SAVITRI™ study, which showed statistically significant and clinically meaningful improvement in depression severity at Day 28 and Day 56 with once-daily oral administration of 1 mg osavampator (NBI-10...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US88023B1035
Tempus AI, Inc.
TEM
LISTED
NASDAQ
Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its RNA-based Tempus xR IVD device. xR IVD will be offered as a life sciences tool to support drug development programs....
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US9467841055
Waystar Holding Corp.
WAY
LISTED
NASDAQ
Waystar Joins S&P SmallCap 600 Index
News Preview
Inclusion underscores durable growth, innovation leadership, and long-term shareholder value
LEHI, Utah and LOUISVILLE, Ky., Sept. 22, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that it has joined the S&P SmallCap 600® Index, effective before the market opens on...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US02155H2004
Altimmune Inc
ALT
LISTED
NASDAQ
INVESTOR ALERT: Berger Montague Advises Altimmune, Inc. (NASDAQ: ALT) Investors to Inquire About a Securities Fraud Class Action by October 6, 2025
News Preview
PHILADELPHIA, Sept. 22, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Altimmune Inc. (NASDAQ: ALT) ("Altimmune" or the "Company") on behalf of investors who purchased or otherwise acquired publicly traded securities of Altimmune between August 10, 2023 through June 25, 2025 (the "Cl...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US74051N1028
Premier Inc
PINC
LISTED
NASDAQ
PINC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Premier, Inc. Is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Premier, Inc. (NASDAQ: PINC) to an affiliate of Patient Square Capital for $28.25 in cash per share is fair to Premier shareholders.
Halper Sadeh encourages Premier shareholders to click here to learn more about their legal rights and options or contact Daniel Sa...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US59267L1070
Metsera, Inc.
MTSR
LISTED
NASDAQ
MTSR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Metsera, Inc. Is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Metsera, Inc. (NASDAQ: MTSR) to Pfizer Inc. is fair to Metsera shareholders. Under the terms of the proposed transaction, Metsera shareholders will receive $47.50 per share in cash at closing, plus a non-transferable contingent value right entitling holders to pote...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US74834L1008
Quest Diagnostics Inc
DGX
LISTED
NYSE
Haystack Oncology and Rutgers Cancer Institute Collaborate in a Clinical Study to Examine Haystack MRD as a Guide for Post-Surgical Treatment for Lung Cancer
News Preview
SECAUCUS, N.J. and NEW BRUNSWICK, N.J., Sept. 22, 2025 /PRNewswire/ -- Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company, today announced a research collaboration with the Rutgers Cancer Institute to evaluate the use of Haystack MRD®, a highly sensitive circulating tumor DNA (ctDNA) minimal residual disease (MRD) test, to help optimize p...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US03528H1095
Anixa Biosciences, Inc.
ANIX
LISTED
NASDAQ
Cleveland Clinic to Present Final Results of Phase 1 Clinical Trial for Anixa Biosciences' Breast Cancer Vaccine at 2025 San Antonio Breast Cancer Symposium
News Preview
Phase 1 Data Highlights Potential of First-in-Class Vaccine to Transform Breast Cancer Treatment and Prevention
Comprehensive Results, Supported by U.S. Department of Defense Funding, to Inform FDA Discussions and Advance Phase 2 Development Plans
SAN JOSE, Calif., Sept. 22, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company")...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
